Published in

American Association for the Advancement of Science, Science Translational Medicine, 451(10), 2018

DOI: 10.1126/scitranslmed.aat3504

Links

Tools

Export citation

Search in Google Scholar

Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy

Journal article published in 2018 by Kieren D. Marini ORCID, David R. Croucher ORCID, Rachael A. McCloy ORCID, Vijesh Vaghjiani ORCID, Alvaro Gonzalez-Rajal ORCID, Jordan F. Hastings ORCID, Venessa Chin ORCID, Anette Szczepny, Kaja Kostyrko ORCID, Cesar Marquez, W. Samantha N. Jayasekara ORCID, Muhammad Alamgeer ORCID, Vishal Boolell, Jeremy Z. R. Han, Todd Waugh ORCID and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Inhibition of activin signaling enhances the efficacy and safety of platinum chemotherapy in lung adenocarcinoma models.